MedTrace Logo

fMRI Neurofeedback With Matter Neuroscience App

NCT06735885 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2025-12-17

No results posted yet for this study

Summary

Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal clinical trial.

Conditions

Interventions

DEVICE

Matter Neuroscience App

An iPhone smartphone application

OTHER

Stock Photos

Stock Photos

OTHER

No Home Training

No Home Training

DEVICE

Personal Photos

Personal Photos

OTHER

Home Training

Home Training

Sponsors & Collaborators

Principal Investigators

  • David Spiegel, MD · Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-12
Primary Completion
2027-06-15
Completion
2028-06-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06735885 on ClinicalTrials.gov